XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Collaboration and Other Agreements - Incyte Corporation (Details)
 3 Months Ended 9 Months Ended 12 Months Ended 24 Months Ended 45 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2017
USD ($)
performanceObligation
Dec. 31, 2018
USD ($)
Sep. 30, 2021
USD ($)
Collaboration And Other Agreements [Line Items]              
Revenues $ 15,662,000 $ 18,253,000 $ 63,300,000 $ 52,192,000      
Incyte Corporation | Incyte MGA012 Agreement              
Collaboration And Other Agreements [Line Items]              
Non-refundable upfront payment         $ 150,000,000    
Potential development and regulatory milestone payments under agreement         420,000,000    
Potential commercial milestone payments under agreement         $ 330,000,000    
Development and regulatory milestones recognized   15,000,000 15,000,000 15,000,000     $ 70,000,000
Number of performance obligations | performanceObligation         2    
Collaborative agreement transaction price         $ 154,000,000    
Variable consideration recognized           $ 4,000,000  
Minimum | Incyte Corporation | Incyte MGA012 Agreement              
Collaboration And Other Agreements [Line Items]              
Potential proceeds from royalties (percent)         15.00%    
Maximum | Incyte Corporation | Incyte MGA012 Agreement              
Collaboration And Other Agreements [Line Items]              
Potential proceeds from royalties (percent)         24.00%    
Revenues From License Agreements | Incyte Corporation | Incyte MGA012 Agreement              
Collaboration And Other Agreements [Line Items]              
Revenues         $ 150,000,000    
Revenues From License Agreements | Incyte Corporation | Incyte MGA012 Agreement - Clinical activities              
Collaboration And Other Agreements [Line Items]              
Revenues 0   0        
Revenues From License Agreements | Incyte Corporation | Incyte MGA012 Clinical Services              
Collaboration And Other Agreements [Line Items]              
Revenues 200,000 $ 700,000 1,000,000 $ 8,100,000      
Revenues From License Agreements | Incyte Corporation | Incyte MGA012 Supply Agreement              
Collaboration And Other Agreements [Line Items]              
Revenues $ 1,400,000   $ 7,400,000